Metropolitan Digital

Men's Weekly


.

Oxford-AstraZeneca vaccine is cheaper than Pfizer's and Moderna's and doesn't require supercold temperature

  • Written by Sanjay Mishra, Project Coordinator & Staff Scientist, Vanderbilt University Medical Center, Vanderbilt University
Oxford-AstraZeneca vaccine is cheaper than Pfizer's and Moderna's and doesn't require supercold temperatureNow there is a third possible vaccine for fighting the COVID-19 pandemic.Jakub Porzycki/NurPhoto via Getty Images

The biopharmaceutical company AstraZeneca has released data on what is now the third promising vaccine candidate against COVID-19 – and it has several advantages over those of its competitors, Pfizer and Moderna.

On Monday,...

Read more: Oxford-AstraZeneca vaccine is cheaper than Pfizer's and Moderna's and doesn't require supercold...

More Articles ...

  1. Testing sewage can give school districts, campuses and businesses a heads-up on the spread of COVID-19
  2. How Biden and Kerry could rebuild America's global climate leadership
  3. 'My vote will be Black' – A wave of Afro-Brazilian women ran for office in 2020 but found glass ceiling hard to break
  4. School suspensions don't just unfairly penalize Black students – they lead to lower grades and 'Black flight'
  5. Republicans didn't lose big in 2020 – they held onto statehouses and the power to influence future elections
  6. These at-home exercises can help older people boost their immune system and overall health in the age of COVID-19
  7. Coronavirus vaccines: health experts identify ways to build public trust
  8. Why do older people heal more slowly?
  9. A century ago, James Weldon Johnson became the first Black person to head the NAACP
  10. Kids as young as 3 years old think YouTube is better for learning than other types of video
Metropolitan republishes selected articles from The Conversation USA with permission

Visit The Conversation to see more